These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23523615)

  • 21. Role of lysophosphatidic acid and rho in glioma cell motility.
    Manning TJ; Parker JC; Sontheimer H
    Cell Motil Cytoskeleton; 2000 Mar; 45(3):185-99. PubMed ID: 10706774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
    Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A.
    Serrill JD; Tan M; Fotso S; Sikorska J; Kasanah N; Hau AM; McPhail KL; Santosa DA; Zabriskie TM; Mahmud T; Viollet B; Proteau PJ; Ishmael JE
    Biochem Pharmacol; 2015 Feb; 93(3):251-65. PubMed ID: 25511868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.
    Chakravarti A; Loeffler JS; Dyson NJ
    Cancer Res; 2002 Jan; 62(1):200-7. PubMed ID: 11782378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
    Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
    J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death.
    Blum R; Jacob-Hirsch J; Amariglio N; Rechavi G; Kloog Y
    Cancer Res; 2005 Feb; 65(3):999-1006. PubMed ID: 15705901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells.
    Li Y; Zhang P; Qiu F; Chen L; Miao C; Li J; Xiao W; Ma E
    Life Sci; 2012 Jun; 90(25-26):962-7. PubMed ID: 22634579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.
    Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS
    Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.
    Chiasserini D; Davidescu M; Orvietani PL; Susta F; Macchioni L; Petricciuolo M; Castigli E; Roberti R; Binaglia L; Corazzi L
    J Proteomics; 2017 Jan; 152():329-338. PubMed ID: 27890797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential.
    Contreras-Lopez R; Elizondo-Vega R; Luque-Campos N; Torres MJ; Pradenas C; Tejedor G; Paredes-Martínez MJ; Vega-Letter AM; Campos-Mora M; Rigual-Gonzalez Y; Oyarce K; Salgado M; Jorgensen C; Khoury M; Garcia-Robles MLÁ; Altamirano C; Djouad F; Luz-Crawford P
    Theranostics; 2021; 11(1):445-460. PubMed ID: 33391485
    [No Abstract]   [Full Text] [Related]  

  • 32. Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma.
    Pruss M; Dwucet A; Tanriover M; Hlavac M; Kast RE; Debatin KM; Wirtz CR; Halatsch ME; Siegelin MD; Westhoff MA; Karpel-Massler G
    Br J Cancer; 2020 Apr; 122(8):1146-1157. PubMed ID: 32115576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma.
    Hoang-Minh LB; Siebzehnrubl FA; Yang C; Suzuki-Hatano S; Dajac K; Loche T; Andrews N; Schmoll Massari M; Patel J; Amin K; Vuong A; Jimenez-Pascual A; Kubilis P; Garrett TJ; Moneypenny C; Pacak CA; Huang J; Sayour EJ; Mitchell DA; Sarkisian MR; Reynolds BA; Deleyrolle LP
    EMBO J; 2018 Dec; 37(23):. PubMed ID: 30322894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.
    Sottnik JL; Lori JC; Rose BJ; Thamm DH
    Clin Exp Metastasis; 2011 Dec; 28(8):865-75. PubMed ID: 21842413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypersensitization of tumor cells to glycolytic inhibitors.
    Liu H; Hu YP; Savaraj N; Priebe W; Lampidis TJ
    Biochemistry; 2001 May; 40(18):5542-7. PubMed ID: 11331019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis.
    Chinopoulos C; Seyfried TN
    ASN Neuro; 2018; 10():1759091418818261. PubMed ID: 30909720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of inhibitors of energy metabolism on the growth of one-cell rabbit ova to blastocysts in vitro.
    Kane MT; Buckley NJ
    J Reprod Fertil; 1977 Mar; 49(2):261-6. PubMed ID: 557551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma.
    Nguyen TTT; Shang E; Shu C; Kim S; Mela A; Humala N; Mahajan A; Yang HW; Akman HO; Quinzii CM; Zhang G; Westhoff MA; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    Nat Commun; 2021 Sep; 12(1):5203. PubMed ID: 34471141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Deoxyglucose, an Inhibitor of Glycolysis, Enhances the Oncolytic Effect of Coxsackievirus.
    Vorobyev PO; Kochetkov DV; Chumakov PM; Zakirova NF; Zotova-Nefedorova SI; Vasilenko KV; Alekseeva ON; Kochetkov SN; Bartosch B; Lipatova AV; Ivanov AV
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities.
    Garofano L; Migliozzi S; Oh YT; D'Angelo F; Najac RD; Ko A; Frangaj B; Caruso FP; Yu K; Yuan J; Zhao W; Di Stefano AL; Bielle F; Jiang T; Sims P; Suvà ML; Tang F; Su XD; Ceccarelli M; Sanson M; Lasorella A; Iavarone A
    Nat Cancer; 2021 Feb; 2(2):141-156. PubMed ID: 33681822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.